NVCR Q1 2023 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$122M-11.2% YoY

Gross Profit

$93M75.8% margin

Operating Income

-$60M-49.3% margin

Net Income

-$53M-43.4% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$23M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$742M

Stockholders' Equity

$432M

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$122M	$138M	-11.2%
Gross Profit	$93M	$110M	-15.7%
Operating Income	-$60M	-$806,000	-7375.1%
Net Income	-$53M	-$5M	-1041.8%

Geographic Segments

UNITED STATES

$85M70%

GERMANY

$15M12%

JAPAN

$9M7%

Others Countries

$8M6%

CHINA

$5M4%